SIMI: Importing Research Peptides to Argentina

SIMI (Sistema Integral de Monitoreo de Importaciones) is the system Argentine customs uses to register, before a shipment ever lands, any formal import into the country. For most research peptide shipments that travel door-to-door by courier, the SIMI filing is handled by the carrier or the customs broker working the shipment — not by the person receiving the package at home.

What SIMI actually is

Argentine customs, which operates under AFIP, built SIMI to replace the older DJAI (Declaración Jurada Anticipada de Importación) after that mechanism lost a dispute at the World Trade Organization. SIMI does the same job inside a different framework: it is an advance declaration filed through the Ventanilla Única de Comercio Exterior (VUCE), the single window for foreign trade, and it gives customs visibility into what is about to enter the country, under what description, at what declared value, and under which tariff code (NCM).

Based on that tariff code, the system sorts the shipment into one of two tracks: an automatic licence, approved on its own within a short window, or a non-automatic licence, which adds review from a specific agency depending on what the goods actually are. SENASA steps in for products of animal or plant origin. ANMAT steps in when the goods are classified as a medicine, a product for human consumption, or a health-related supply.

A peptide declared on the invoice for what it is — laboratory research material, not a medicine and not a consumer product — does not fall into that second category. But the final classification is made by customs based on the description, the invoice, and the tariff code entered by whoever handles the clearance, not a label the supplier chooses to print.

Does every shipment need its own SIMI?

Not every shipment follows the same path. A formal commercial import, carried out by a company registered with a CUIT in the Registro de Importadores y Exportadores, files its own SIMI for each operation. A door-to-door courier shipment, on the other hand, usually moves under a simplified postal regime, where the clearance is handled by the logistics operator — the courier or its broker — as part of the service. The recipient is not the one who has to register in the VUCE or file a declaration under their own name.

That distinction matters for anyone sourcing research peptides from Argentina: the SIMI filing, when it applies, is the responsibility of whoever handles the formal customs clearance, not a step the buyer has to complete before the package leaves origin.

That said, each courier and each logistics route can operate under different rules depending on the declared value, the weight, and the tariff code of the shipment, and those rules change over time. For a specific order, the right source is not a generic guide online but the AFIP website itself, or a direct question to the broker handling that particular shipment.

What documentation travels with a research peptide order

What does depend on the supplier is the documentation that travels with the batch and correctly describes what the goods are. PeptoClinic prepares that file so the invoice description is consistent with what the vial actually contains: laboratory research material, not a pharmaceutical product and not a supplement.

That documentation includes the invoice, with the compound description and its declared use, and the certificate of analysis (CoA) for the batch, issued by the laboratory that ran the purity testing. How to read a CoA, and what it needs to say to be trustworthy, is explained on the quality page — it is the question most worth getting right, because a certificate nobody can verify is worthless whether or not it is attached to the shipment.

The physical format of the batch matters for logistics too, not only for customs: the material travels as lyophilised powder in a sealed vial, with no cold chain, because in that state it is stable at room temperature for weeks. Cold only becomes necessary once the powder has been reconstituted, not during transport. The full detail of how a shipment is packed and protected is on the shipping page.

Compounds most asked about from Argentina

Among the requests that come in from Argentina, a handful of compounds come up most often, and each has its own page covering what specifically applies to shipments into the country. Retatrutide, BPC-157, and MOTS-c are the three most frequently asked about, and each one has its own published laboratory report and its own catalogue entry.

Laboratory material, not for human use

Everything PeptoClinic supplies is research material — Research Use Only (RUO) — intended for in vitro and laboratory research. Nothing on this site is a medicine, a supplement, or a food, and nothing is approved or intended for human or veterinary consumption, diagnosis, or treatment. No claim about these compounds has been evaluated by ANMAT, the FDA, or any equivalent authority. PeptoClinic is not a pharmacy, a clinic, a telehealth provider, or a source of usage or dosing guidance: requests asking for a protocol intended for use in people are declined.